The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.
Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which tests to ...
Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which tests to ...
Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road to acceptance.